| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/01/2015 | US20150005270 Compositions for the treatment of gastrointestinal inflammation |
| 01/01/2015 | US20150005269 Treatment of Heart Failure and Sudden Cardiac Death |
| 01/01/2015 | US20150005266 Topical compositions for treatment of skin conditions |
| 01/01/2015 | US20150005251 Substituted nucleosides, nucleotides and analogs thereof |
| 01/01/2015 | US20150005246 Use of Jasmonate to Treat Bladder Dysfunction |
| 01/01/2015 | US20150005234 Soft tissue implant |
| 01/01/2015 | US20150005232 Indazole derivatives |
| 01/01/2015 | US20150004258 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 01/01/2015 | US20150004233 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| 01/01/2015 | US20150004226 Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| 01/01/2015 | US20150004224 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
| 01/01/2015 | US20150004219 Stable liposomes for drug delivery |
| 01/01/2015 | US20150004184 Elastin digest compositions and methods utilizing same |
| 01/01/2015 | US20150004181 Benzazole Derivatives as Histamine H4 Receptor Ligands |
| 01/01/2015 | US20150004167 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/01/2015 | US20150004163 Adjuvant combinations comprising an nkt activator, a cd40 agent, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 01/01/2015 | US20150004162 Surrogate binding proteins |
| 01/01/2015 | US20150004157 Osteopontin isoform a inhibitors and methods of use |
| 01/01/2015 | US20150004152 Treatment of glycogen storage disease type ii |
| 01/01/2015 | US20150004151 Use of hsp70 as a regulator of enzymatic activity |
| 01/01/2015 | US20150004136 Responsiveness to angiogenesis inhibitors |
| 01/01/2015 | US20150004135 2'-4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/01/2015 | US20150004134 Treatment of cancer with heterocyclic inhibitors of glutaminase |
| 12/31/2014 | CN204050372U 控释药物蚊虫叮咬贴 Controlled release drug mosquito bites stickers |
| 12/31/2014 | CN104248763A 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途 An opioid antagonist for reducing endothelial cell proliferation and migration purposes |
| 12/31/2014 | CN103070838B 含有固体分散体的固体制剂及其制备方法 The solid preparation and preparation method of a solid dispersion comprising |
| 12/31/2014 | CN103055322B 一种靶向缓释载药纳米微球及其制备方法 A slow-release drug-loaded nanoparticles targeting its preparation method |
| 12/31/2014 | CN102772357B 用于持续释放多巴胺受体激动剂的可植入聚合物装置 For the sustained release of dopamine agonist implantable polymeric device |
| 12/30/2014 | US8921545 Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones |
| 12/30/2014 | US8921521 Macrocyclic modulators of the Ghrelin receptor |
| 12/30/2014 | US8921519 Single chain fusion polypeptides comprising soluble light cytokine domains |
| 12/30/2014 | US8921415 Polymorphs of darunavir |
| 12/30/2014 | US8921414 Spiroketals |
| 12/30/2014 | US8921395 Crystalline forms of a biphenyl compound |
| 12/30/2014 | US8921393 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/30/2014 | US8921390 Medicaments for inhibiting thrombus formation |
| 12/30/2014 | US8921388 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 12/30/2014 | US8921384 Spiro[2.4]heptanes for treatment of flaviviridae infections |
| 12/30/2014 | US8921383 Thiazolopyrimidine compounds |
| 12/30/2014 | US8921381 Inhibitors of secretion of hepatitis B virus antigens |
| 12/30/2014 | US8921367 Use of AMG 900 for the treatment of cancer |
| 12/30/2014 | US8921365 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 12/30/2014 | US8921357 Pyridazinone derivatives |
| 12/30/2014 | US8921355 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors |
| 12/30/2014 | US8921345 Pharmaceutical composition for emergency contraception |
| 12/30/2014 | US8921341 Antiviral compounds |
| 12/30/2014 | US8921321 Therapeutic strategies for prevention and treatment of alzheimer's disease |
| 12/30/2014 | US8921320 Targeted osmotic lysis of cancer cells |
| 12/30/2014 | US8921307 Synthetic linear apelin mimetics for the treatment of heart failure |
| 12/30/2014 | US8921306 Nociceptin mimetics |
| 12/30/2014 | US8920851 Treatment of neurodegenerative diseases |
| 12/30/2014 | US8920838 Delayed-release glucocorticoid treatment of rheumatoid disease |
| 12/30/2014 | US8920824 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 12/30/2014 | US8920800 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 12/30/2014 | US8920794 Method for treating filtration failure after trabeculectomy surgery |
| 12/30/2014 | US8920790 Uses of IL-12 in hematopoiesis |
| 12/30/2014 | US8920782 Topical bioadhesive formulations |
| 12/30/2014 | US8920774 Drug having regulatory cell ligand contained in liposome |
| 12/30/2014 | US8920715 Sterilant composition and system |
| 12/30/2014 | CA2403533C Methods and systems for enhancing fluid flow through an obstructed vascular site |
| 12/25/2014 | US20140378546 Method of treating postural reflex abnormality caused by parkinson's disease |
| 12/25/2014 | US20140378541 Synthetic Epigallocatechin Gallate (EGCG) Analogs |
| 12/25/2014 | US20140378534 Treatment and diagnosis of colon cancer |
| 12/25/2014 | US20140378531 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| 12/25/2014 | US20140378529 Collateral gene inactivation biomarkers and targets for cancer therapy |
| 12/25/2014 | US20140378528 Biomarkers of mir-34 activity |
| 12/25/2014 | US20140378522 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 12/25/2014 | US20140378516 Compositions, methods of use, and methods of treatment |
| 12/25/2014 | US20140378512 Composition for improving cognition and memory |
| 12/25/2014 | US20140378505 Sns-595 and methods of using the same |
| 12/25/2014 | US20140378503 Anti-cancer compounds |
| 12/25/2014 | US20140378502 Par1 Inhibitors for Use in the Treatment or Prevention of Paramyxoviridae Infections |
| 12/25/2014 | US20140378501 Scopolamine for the treatment of depression and anxiety |
| 12/25/2014 | US20140378495 Rifaximin derivative and uses thereof |
| 12/25/2014 | US20140378493 Fused Bicyclic Oxazolidinone CETP Inhibitor |
| 12/25/2014 | US20140378491 Cycloalkyl-substituted pyrimidinedione compounds |
| 12/25/2014 | US20140378489 Methods of preventing and treating diabetes by inhibiting serotonin synthesis |
| 12/25/2014 | US20140378485 Quinazolinone derivatives as hcv inhibitors |
| 12/25/2014 | US20140378482 Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer |
| 12/25/2014 | US20140378478 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use |
| 12/25/2014 | US20140378466 Derivatives of n-(arylamino) sulfonamides as inhibitors of mek |
| 12/25/2014 | US20140378465 Method of treating diabetes |
| 12/25/2014 | US20140378464 Pyrimidinedione compounds |
| 12/25/2014 | US20140378449 Triazolopyridine jak inhibitor compounds and methods |
| 12/25/2014 | US20140378445 Methods for treating vascular leak syndrome |
| 12/25/2014 | US20140378442 Phthalazinone derivatives |
| 12/25/2014 | US20140378440 Baclofen and acamprosate based therapy of neurological disorders |
| 12/25/2014 | US20140378423 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors |
| 12/25/2014 | US20140378421 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 12/25/2014 | US20140378416 Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
| 12/25/2014 | US20140378411 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 12/25/2014 | US20140378409 Effect potentiator for antitumor agents |
| 12/25/2014 | US20140378397 Carnitine Retention |
| 12/25/2014 | US20140378385 Histone Deacetylase 6 Selective Inhibitors for the Treatment of Bone Disease |
| 12/25/2014 | US20140378376 Dosage Regime for Apolipoprotein Formulations |
| 12/25/2014 | US20140377389 Pomegranate extract for use in treating rhinitis and sinusitis |
| 12/25/2014 | US20140377387 Compositions and Methods for Modulating Lipid Composition |
| 12/25/2014 | US20140377336 Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma |
| 12/25/2014 | US20140377329 Sublingual films |
| 12/25/2014 | US20140377327 Extended release drug-delivery contact lenses and methods of making |